Alpha Cognition Inc
NASDAQ:ACOG 4:00:00 PM EDT
| Market Cap (Intraday) | 148.49M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $9.24 |
| 50-Day MA | $8.11 |
| 200-Day MA | N/A |
Alpha Cognition Inc Stock, NASDAQ:ACOG
750 West Pender Street, Suite 1200, Vancouver, British Columbia V6C 2T8
Canada
Phone:
Number of Employees: 5
Description
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.